1. Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, Trends
4. Voice of
Customer
5. Global Spatial
Genomics and Transcriptomics Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1. By Technique
(Spatial Transcriptomics v/s Spatial Genomics Analysis)
5.2.2. By
Product Type (Instruments, Consumables, Software)
5.2.3. By
Application (Translational Research v/s Drug discovery & development)
5.2.4. By
End User (Pharmaceutical & Biotechnology companies, Contract Research
Organizations, Academic & Research Institutes)
5.2.5. By
Region (North America, Europe, Asia Pacific, South America, Middle East &
Africa)
5.2.6. By
Company (2024)
5.3. Market
Map
5.3.1 By
Technique
5.3.2 By
Product Type
5.3.3 By
Application
5.3.4 By
End User
5.3.5 By
Region
6. North
America Spatial Genomics and Transcriptomics Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1. By
Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
6.2.2. By
Product Type (Instruments, Consumables, Software)
6.2.3. By
Application (Translational Research v/s Drug discovery & development)
6.2.4. By
End User (Pharmaceutical & Biotechnology companies, Contract Research
Organizations, Academic & Research Institutes)
6.2.5. By
Country
6.3. North
America: Country Analysis
6.3.1. United
States Spatial Genomics and Transcriptomics Market Outlook
6.3.1.1. Market
Size & Forecast
6.3.1.1.1. By
Value
6.3.1.2. Market
Share & Forecast
6.3.1.2.1. By
Technique
6.3.1.2.2. By
Product Type
6.3.1.2.3. By
Application
6.3.1.2.4. By
End User
6.3.2. Canada
Spatial Genomics and Transcriptomics Market Outlook
6.3.2.1. Market
Size & Forecast
6.3.2.1.1. By
Value
6.3.2.2. Market
Share & Forecast
6.3.2.2.1. By
Technique
6.3.2.2.2. By
Product Type
6.3.2.2.3. By
Application
6.3.2.2.4. By
End User
6.3.3. Mexico
Spatial Genomics and Transcriptomics Market Outlook
6.3.3.1. Market
Size & Forecast
6.3.3.1.1. By
Value
6.3.3.2. Market
Share & Forecast
6.3.3.2.1. By
Technique
6.3.3.2.2. By
Product Type
6.3.3.2.3. By
Application
6.3.3.2.4. By
End User
7. Europe
Spatial Genomics and Transcriptomics Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1. By
Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
7.2.2. By
Product Type (Instruments, Consumables, Software)
7.2.3. By
Application (Translational Research v/s Drug discovery & development)
7.2.4. By
End User (Pharmaceutical & Biotechnology companies, Contract Research
Organizations, Academic & Research Institutes)
7.2.5. By
Country
7.3. Europe:
Country Analysis
7.3.1. France
Spatial Genomics and Transcriptomics Market Outlook
7.3.1.1. Market
Size & Forecast
7.3.1.1.1. By
Value
7.3.1.2. Market
Share & Forecast
7.3.1.2.1. By
Technique
7.3.1.2.2. By
Product Type
7.3.1.2.3. By
Application
7.3.1.2.4. By
End User
7.3.2. Germany
Spatial Genomics and Transcriptomics Market Outlook
7.3.2.1. Market
Size & Forecast
7.3.2.1.1. By
Value
7.3.2.2. Market
Share & Forecast
7.3.2.2.1. By
Technique
7.3.2.2.2. By
Product Type
7.3.2.2.3. By
Application
7.3.2.2.4. By
End User
7.3.3. United
Kingdom Spatial Genomics and Transcriptomics Market Outlook
7.3.3.1. Market
Size & Forecast
7.3.3.1.1. By
Value
7.3.3.2. Market
Share & Forecast
7.3.3.2.1. By
Technique
7.3.3.2.2. By
Product Type
7.3.3.2.3. By
Application
7.3.3.2.4. By
End User
7.3.4. Italy
Spatial Genomics and Transcriptomics Market Outlook
7.3.4.1. Market
Size & Forecast
7.3.4.1.1. By
Value
7.3.4.2. Market
Share & Forecast
7.3.4.2.1. By
Technique
7.3.4.2.2. By
Product Type
7.3.4.2.3. By
Application
7.3.4.2.4. By
End User
7.3.5. Spain
Spatial Genomics and Transcriptomics Market Outlook
7.3.5.1. Market
Size & Forecast
7.3.5.1.1. By
Value
7.3.5.2. Market
Share & Forecast
7.3.5.2.1. By
Technique
7.3.5.2.2. By
Product Type
7.3.5.2.3. By
Application
7.3.5.2.4. By
End User
8. Asia-Pacific
Spatial Genomics and Transcriptomics Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1. By
Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
8.2.2. By
Product Type (Instruments, Consumables, Software)
8.2.3. By
Application (Translational Research v/s Drug discovery & development)
8.2.4. By
End User (Pharmaceutical & Biotechnology companies, Contract Research
Organizations, Academic & Research Institutes)
8.2.5. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Spatial Genomics and Transcriptomics Market Outlook
8.3.1.1. Market
Size & Forecast
8.3.1.1.1. By
Value
8.3.1.2. Market
Share & Forecast
8.3.1.2.1. By
Technique
8.3.1.2.2. By
Product Type
8.3.1.2.3. By
Application
8.3.1.2.4. By
End User
8.3.2. India
Spatial Genomics and Transcriptomics Market Outlook
8.3.2.1. Market
Size & Forecast
8.3.2.1.1. By
Value
8.3.2.2. Market
Share & Forecast
8.3.2.2.1. By
Technique
8.3.2.2.2. By
Product Type
8.3.2.2.3. By
Application
8.3.2.2.4. By
End User
8.3.3. Japan
Spatial Genomics and Transcriptomics Market Outlook
8.3.3.1. Market
Size & Forecast
8.3.3.1.1. By
Value
8.3.3.2. Market
Share & Forecast
8.3.3.2.1. By
Technique
8.3.3.2.2. By
Product Type
8.3.3.2.3. By
Application
8.3.3.2.4. By
End User
8.3.4. South
Korea Spatial Genomics and Transcriptomics Market Outlook
8.3.4.1. Market
Size & Forecast
8.3.4.1.1. By
Value
8.3.4.2. Market
Share & Forecast
8.3.4.2.1. By
Technique
8.3.4.2.2. By
Product Type
8.3.4.2.3. By
Application
8.3.4.2.4. By
End User
8.3.5. Australia
Spatial Genomics and Transcriptomics Market Outlook
8.3.5.1. Market
Size & Forecast
8.3.5.1.1. By
Value
8.3.5.2. Market
Share & Forecast
8.3.5.2.1. By
Technique
8.3.5.2.2. By
Product Type
8.3.5.2.3. By
Application
8.3.5.2.4. By
End User
9. South
America Spatial Genomics and Transcriptomics Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1. By
Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
9.2.2. By
Product Type (Instruments, Consumables, Software)
9.2.3. By
Application (Translational Research v/s Drug discovery & development)
9.2.4. By
End User (Pharmaceutical & Biotechnology companies, Contract Research
Organizations, Academic & Research Institutes)
9.2.5. By
Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Spatial Genomics and Transcriptomics Market Outlook
9.3.1.1. Market
Size & Forecast
9.3.1.1.1. By
Value
9.3.1.2. Market
Share & Forecast
9.3.1.2.1. By
Technique
9.3.1.2.2. By
Product Type
9.3.1.2.3. By
Application
9.3.1.2.4. By
End User
9.3.2. Argentina
Spatial Genomics and Transcriptomics Market Outlook
9.3.2.1. Market
Size & Forecast
9.3.2.1.1. By
Value
9.3.2.2. Market
Share & Forecast
9.3.2.2.1. By
Technique
9.3.2.2.2. By
Product Type
9.3.2.2.3. By
Application
9.3.2.2.4. By
End User
9.3.3. Colombia
Spatial Genomics and Transcriptomics Market Outlook
9.3.3.1. Market
Size & Forecast
9.3.3.1.1. By
Value
9.3.3.2. Market
Share & Forecast
9.3.3.2.1. By
Technique
9.3.3.2.2. By
Product Type
9.3.3.2.3. By
Application
9.3.3.2.4. By
End User
10. Middle East and
Africa Spatial Genomics and Transcriptomics Market Outlook
10.1. Market
Size & Forecast
10.1.1. By
Value
10.2. Market
Share & Forecast
10.2.1. By
Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
10.2.2. By
Product Type (Instruments, Consumables, Software)
10.2.3. By
Application (Translational Research v/s Drug discovery & development)
10.2.4. By
End User (Pharmaceutical & Biotechnology companies, Contract Research
Organizations, Academic & Research Institutes)
10.2.5. By
Country
10.3. MEA:
Country Analysis
10.3.1. South
Africa Spatial Genomics and Transcriptomics Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1. By
Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1. By
Technique
10.3.1.2.2. By
Product Type
10.3.1.2.3. By
Application
10.3.1.2.4. By
End User
10.3.2. Saudi
Arabia Spatial Genomics and Transcriptomics Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1. By
Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1. By
Technique
10.3.2.2.2. By
Product Type
10.3.2.2.3. By
Application
10.3.2.2.4. By
End User
10.3.3. UAE
Spatial Genomics and Transcriptomics Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1. By
Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1. By
Technique
10.3.3.2.2. By
Product Type
10.3.3.2.3. By
Application
10.3.3.2.4. By
End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends &
Developments
12.1. Recent
Development
12.2. Mergers
& Acquisitions
12.3. Product
Launches
13. Global Spatial
Genomics and Transcriptomics Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1. Competition
in the Industry
14.2. Potential
of New Entrants
14.3. Power
of Suppliers
14.4. Power
of Customers
14.5. Threat
of Substitute Products
15. Competitive Landscape
15.1. 10X Genomics Inc.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As
Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Akoya Bioscience Ltd.
15.3. Biospyder Technologies Inc.
15.4. BioTechne Corporation
15.5. Dovetail Genomics LLC
15.6. Fluidigm Corporation
15.7. Genomic Vision SA
15.8. Illumina Inc.
15.9. Lunaphore Technologies SA
15.10. Nanostring
Technolgies Inc
16.
Strategic Recommendations
17.
About Us & Disclaimer